NON CURRENT ASSETS	6 Months Ended
Jun. 30, 2026
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
NON CURRENT ASSETS	6. NON CURRENT ASSETS During March 2025, the Company entered into an agreement with Gensignia Life Sciences Inc. to buy the entire issued share capital of Gensignia IP Limited (the “GIP Shares”) from Gensignia Life Sciences Inc., together with all records and intellectual property relating to Gensignia’s interest in proprietary microRNA Signature Classifier (“MSC”) test. The Company agreed and issued 3,750,000 shares at $0.40 as consideration for the same. However, this transaction has not yet been concluded and thus, the consideration paid amounting to USD 1.5 million in form of shares is classified as a Non-current Asset.

NON CURRENT ASSETS

6 Months Ended

Jun. 30, 2026

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

6. NON CURRENT ASSETS

During March 2025, the Company entered into an agreement with Gensignia Life Sciences Inc. to buy the entire issued share capital of Gensignia IP Limited (the “GIP Shares”) from Gensignia Life Sciences Inc., together with all records and intellectual property relating to Gensignia’s interest in proprietary microRNA Signature Classifier (“MSC”) test. The Company agreed and issued 3,750,000 shares at $0.40 as consideration for the same. However, this transaction has not yet been concluded and thus, the consideration paid amounting to USD 1.5 million in form of shares is classified as a Non-current Asset.